i n f l a r x

Loading

Impressum Privacy policy

Contact us

+49 3641 508 180

info@inflarx.de

Address

InflaRx N.V.

Winzerlaer Str. 2, 07745 Jena

Press Release
Home Investors Press Releases Press Release

InflaRx Initiates Phase III Clinical Program with Vilobelimab in Hidradenitis Suppurativa

Jan 05, 2022

Time to read 4 Minutes
  Download PDF


Back